BWS Financial Inc

BWS provides independent stock specific research focused on companies with distinct value that are going through a special situation where there is a tangible catalyst not priced in. The catalyst can be anything from new product, restructuring, M&A, management change, change in business strategy, etc. BWS’s focus is to understand the change and evaluate the potential return for investors.

BWS utilizes a self formed proprietary approach in discovering stocks by putting great emphasis on deep research. BWS does generate short recommendations following a similar criteria.

Independent Stock Specific Research

IPAR: Multiple Brands for Success in 2022, PT to $125

Founder, BWS Financial Inc

Hamed Khorsand

Founder

Equity Bottom-Up

<ul>
<li>IPAR updated its fourth quarter 2021 outlook by raising its sales forecast for the period. IPAR’s management had expressed caution when IPAR reported third quarter results</li>
<li>IPAR is forecasting Q4 sales of $210.8 million compared to our estimate of $144.7 million. The initial guidance IPAR had provided was conservative and based on limited clarity </li>
<li>IPAR remains one of our favorite growth stories in 2022. IPAR has expanded its brand portfolio and has a fragrance lineup that should result in sales growing by double digits</li>
</ul>


IPAR updated its fourth quarter 2021 outlook by raising its sales forecast for the period. IPAR’s management had expressed caution when IPAR reported third quarter results
IPAR is forecasting Q4 sales of $210.8 million compared to our estimate of $144.7 million. The initial guidance IPAR had provided was conservative and based on limited clarity 
IPAR remains one of our favorite growth stories in 2022. IPAR has expanded its brand portfolio and has a fragrance lineup that should result in sales growing by double digits


Inter Parfums

IPAR: 2021 Momentum Continues in 2022